O3125

Ouabain octahydrate

From plant seeds (Strophantus gratus), ≥95% (HPLC), steroid hormone, powder

• Synonim(y): 1β,3β,5β,11α,14,19-Hexahydroxycard-20(22)-enolide 3-(6-deoxy-α-L-mannopyranoside), Acocantherine, G-Strophanthin
• Wzór empiryczny (zapis Hilla): C₂₉H₄₄O₁₂ · 8H₂O
• Numer CAS: 11018-89-6
• Masa cząsteczkowa: 728.77
• NACRES: NA.77
• PubChem Substance ID: 24278610
• UNSPSC Code: 12352200
• EC Number: 211-139-3
• MDL number: MFCD00149240
• Beilstein/REAXYS Number: 101712
• Assay: ≥95% (HPLC)
• Form: powder

Właściwości

• Nazwa produktu: Ouabain octahydrate, ≥95% (HPLC), powder
• biological source: plant seeds (Strophantus gratus)
• Quality Segment: 200
• assay: ≥95% (HPLC)
• form: powder
• optical activity: [α]25/D −31 to −32.5° in H₂O(lit.)
• impurities: ~8 mol/mol water
• color: white
• mp: 260 °C
• solubility: H₂O: 10 mg/mL (cold), ethanol: 10 mg/mL, H₂O: 50 mg/mL (hot)
• ε (extinction coefficient): 15.5 at 220 nm in H₂O at 1 mM
• storage temp.: room temp
• SMILES string: O.O.O.O.O.O.O.O.C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O
• InChI: 1S/C29H44O12.8H2O/c1-13-22(34)23(35)24(36)25(40-13)41-15-8-19(32)28(12-30)21-17(3-5-27(28,37)9-15)29(38)6-4-16(14-7-20(33)39-11-14)26(29,2)10-18(21)31;;;;;;;;/h7,13,15-19,21-25,30-32,34-38H,3-6,8-12H2,1-2H3;8*1H2/t13-,15-,16+,17+,18+,19+,21+,22-,23+,24+,25-,26+,27-,28+,29-;;;;;;;;/m0......../s1
• InChI key: TYBARJRCFHUHSN-DMJRSANLSA-N
• Gene Information: human ... ATIC(471) ; rat ... Atp1b1(25650)

Opis

General description

Ouabain is a steroid hormone, naturally present in mammals.

Application

Ouabain octahydrate has been used:

• to determine the effect of salt and ammonia in the external environment on the rate of activity of Na⁺ /K⁺ in either silver or golden perch
• in the basolateral compartment to induce maximal baseline short-circuit current in rat fetal distal lung epithelial (FDLE) cells
• as an Na⁺/K⁺ ATPase inhibitor to study the relation between blister formation and adenosine triphosphate (ATP) dependent maintenance of plasma membrane homeostasis

Biochem/physiol Actions

Ouabain has its specific binding site on integral proteins of the plasma membrane. Heart disease is treated using ouabain derivatives. Increased ouabain production is observed during exercise in humans. Abnormally high levels of ouabain are indicated in congestive heart failure and hypertension. Ouabain signalling affects intracellular calcium levels, which is known to activate nuclear factor κB (NFκB).

Cardiac glycoside, inhibits Na(+)/K(+) ATPase, regulates transcription of MDR (increase, Pgp) and MRP (increase MRP1 and decrease CFTR, cyctic fibrosis transport receptor or cAMP-activated Cl- channel) genes, also alters localization of MRP1. Ouabain resistance is associated with appearance of Na(+)/K(+) ATPase isoforms with low binding affinity.

Features and Benefits

This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.

Disclaimer

Aqueous solutions can be autoclaved.

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS06,GHS08
• signalword: Danger
• hcodes: H300,H331,H373
• pcodes: P260 - P264 - P271 - P301 + P310 - P304 + P340 + P311 - P314
• Hazard Classifications: Acute Tox. 1 Oral - Acute Tox. 3 Inhalation - STOT RE 2
• Klasa składowania: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• wgk: WGK 3